BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21034692)

  • 41. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    Goldberg JF; Burdick KE; Endick CJ
    Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.
    Toniolo RA; Silva M; Fernandes FBF; Amaral JAMS; Dias RDS; Lafer B
    J Neural Transm (Vienna); 2018 Feb; 125(2):247-257. PubMed ID: 29177955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.
    Vieta E; Manuel Goikolea J; Martínez-Arán A; Comes M; Verger K; Masramon X; Sanchez-Moreno J; Colom F
    J Clin Psychiatry; 2006 Mar; 67(3):473-7. PubMed ID: 16649836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
    Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
    J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
    Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
    J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.
    Zeinoddini A; Sorayani M; Hassanzadeh E; Arbabi M; Farokhnia M; Salimi S; Ghaleiha A; Akhondzadeh S
    Depress Anxiety; 2015 Mar; 32(3):167-73. PubMed ID: 25620378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
    Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
    Furey ML; Drevets WC
    Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
    Savitz JB; Teague TK; Misaki M; Macaluso M; Wurfel BE; Meyer M; Drevets D; Yates W; Gleason O; Drevets WC; Preskorn SH
    Transl Psychiatry; 2018 Jan; 8(1):27. PubMed ID: 29362444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
    Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
    J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
    McIntyre RS; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Rosenblat JD; Brietzke E; Soczynska JK; Cosgrove VE; Miller S; Fischer EG; Kramer NE; Dunlap K; Suppes T; Mansur RB
    JAMA Psychiatry; 2019 Aug; 76(8):783-790. PubMed ID: 31066887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H
    J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
    Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
    Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial.
    McElroy SL; Martens BE; Mori N; Blom TJ; Casuto LS; Hawkins JM; Keck PE
    Int Clin Psychopharmacol; 2015 Jan; 30(1):6-13. PubMed ID: 25340384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levetiracetam for treatment-refractory posttraumatic stress disorder.
    Kinrys G; Wygant LE; Pardo TB; Melo M
    J Clin Psychiatry; 2006 Feb; 67(2):211-4. PubMed ID: 16566615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
    Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
    Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
    Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Husain MI; Chaudhry IB; Khoso AB; Kiran T; Khan N; Ahmad F; Hodsoll J; Husain MO; Naqvi HA; Nizami AT; Chaudhry N; Khan HA; Minhas F; Meyer JH; Ansari MA; Mulsant BH; Husain N; Young AH
    JAMA Netw Open; 2023 Feb; 6(2):e230147. PubMed ID: 36808239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.